HUP0001185A3 - 1-phenylalkyl-1,2,3,6-tetrahydropyridines, process for producing them and pharmaceutical compositions containing them - Google Patents

1-phenylalkyl-1,2,3,6-tetrahydropyridines, process for producing them and pharmaceutical compositions containing them

Info

Publication number
HUP0001185A3
HUP0001185A3 HU0001185A HUP0001185A HUP0001185A3 HU P0001185 A3 HUP0001185 A3 HU P0001185A3 HU 0001185 A HU0001185 A HU 0001185A HU P0001185 A HUP0001185 A HU P0001185A HU P0001185 A3 HUP0001185 A3 HU P0001185A3
Authority
HU
Hungary
Prior art keywords
tetrahydropyridines
phenylalkyl
producing
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0001185A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HUP0001185A2 publication Critical patent/HUP0001185A2/hu
Publication of HUP0001185A3 publication Critical patent/HUP0001185A3/hu
Publication of HU224347B1 publication Critical patent/HU224347B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HU0001185A 1996-12-13 1997-12-12 1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények HU224347B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615335A FR2757160B1 (fr) 1996-12-13 1996-12-13 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1997/002286 WO1998025903A1 (fr) 1996-12-13 1997-12-12 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer

Publications (3)

Publication Number Publication Date
HUP0001185A2 HUP0001185A2 (hu) 2000-10-28
HUP0001185A3 true HUP0001185A3 (en) 2002-10-28
HU224347B1 HU224347B1 (hu) 2005-08-29

Family

ID=9498641

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001185A HU224347B1 (hu) 1996-12-13 1997-12-12 1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények

Country Status (32)

Country Link
US (1) US6034090A (hu)
EP (1) EP0950048B1 (hu)
JP (1) JP3881384B2 (hu)
KR (1) KR100560358B1 (hu)
CN (1) CN1129579C (hu)
AT (1) ATE202561T1 (hu)
AU (1) AU730143B2 (hu)
BR (1) BR9713916A (hu)
CA (1) CA2275353C (hu)
CY (1) CY2274B1 (hu)
CZ (1) CZ289789B6 (hu)
DE (1) DE69705429T2 (hu)
DK (1) DK0950048T3 (hu)
EE (1) EE03763B1 (hu)
ES (1) ES2160977T3 (hu)
FR (1) FR2757160B1 (hu)
GR (1) GR3036643T3 (hu)
HK (1) HK1023997A1 (hu)
HU (1) HU224347B1 (hu)
IL (1) IL130003A (hu)
IS (1) IS1969B (hu)
NO (1) NO312720B1 (hu)
NZ (1) NZ336033A (hu)
PL (1) PL190789B1 (hu)
PT (1) PT950048E (hu)
RS (1) RS49807B (hu)
RU (1) RU2189975C2 (hu)
SI (1) SI0950048T1 (hu)
SK (1) SK283331B6 (hu)
TR (1) TR199901291T2 (hu)
UA (1) UA52707C2 (hu)
WO (1) WO1998025903A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
FR2832405B1 (fr) 2001-11-19 2004-12-10 Sanofi Synthelabo Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
SK78699A3 (en) 2000-01-18
PL334071A1 (en) 2000-01-31
CY2274B1 (en) 2003-07-04
FR2757160A1 (fr) 1998-06-19
ES2160977T3 (es) 2001-11-16
US6034090A (en) 2000-03-07
CN1240427A (zh) 2000-01-05
NO992869L (no) 1999-06-11
IL130003A (en) 2004-09-27
EP0950048B1 (fr) 2001-06-27
GR3036643T3 (en) 2001-12-31
EE03763B1 (et) 2002-06-17
EE9900237A (et) 1999-12-15
CZ211399A3 (cs) 2000-09-13
RU2189975C2 (ru) 2002-09-27
KR20000069422A (ko) 2000-11-25
KR100560358B1 (ko) 2006-03-14
CZ289789B6 (cs) 2002-04-17
CA2275353C (en) 2007-05-22
EP0950048A1 (fr) 1999-10-20
JP3881384B2 (ja) 2007-02-14
ATE202561T1 (de) 2001-07-15
IS1969B (is) 2004-12-15
IS5075A (is) 1999-06-10
CA2275353A1 (en) 1998-06-18
TR199901291T2 (xx) 1999-10-21
DE69705429T2 (de) 2002-05-16
HUP0001185A2 (hu) 2000-10-28
NO992869D0 (no) 1999-06-11
DE69705429D1 (de) 2001-08-02
PT950048E (pt) 2001-12-28
IL130003A0 (en) 2000-02-29
HU224347B1 (hu) 2005-08-29
WO1998025903A1 (fr) 1998-06-18
FR2757160B1 (fr) 1999-03-12
BR9713916A (pt) 2000-02-29
HK1023997A1 (en) 2000-09-29
AU5489398A (en) 1998-07-03
SI0950048T1 (en) 2001-10-31
JP2001505902A (ja) 2001-05-08
PL190789B1 (pl) 2006-01-31
CN1129579C (zh) 2003-12-03
YU24399A (sh) 2001-07-10
UA52707C2 (uk) 2003-01-15
DK0950048T3 (da) 2001-09-24
RS49807B (sr) 2008-08-07
NZ336033A (en) 2000-12-22
SK283331B6 (sk) 2003-06-03
AU730143B2 (en) 2001-03-01
NO312720B1 (no) 2002-06-24

Similar Documents

Publication Publication Date Title
HUP9900055A3 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003141A3 (en) 4-phenylpiperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9601529A3 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP0000323A3 (en) N-substituted 2-cyanopyrrolidine derivatives, process for producing them and pharmaceutical compositions containing them
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
HUP9603433A3 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
HUT70616A (en) Carboxamides, pharmaceutical compositions containing them and process for producing them
HUP9602511A3 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HUP9701264A3 (en) Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them
HUP0004334A2 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9602681A1 (en) Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9601034A3 (en) Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them
HUP9901473A3 (en) 2,3-benzodiazepine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9701561A3 (en) N-acylated piperidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
HU9503801D0 (en) Substituted 4-phenyl-thiazol derviatives, process for producing them and pharmaceutical compositions containing them
HU9602640D0 (en) Substituted benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUT74615A (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same
HUP9602748A2 (en) Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them
HU9400934D0 (en) Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them
HUP9900105A3 (en) Momopiperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700989A2 (en) Ortho-substituted benzoyl-guanidines, process for producing them, and pharmaceutical compositions containing them
HUP9601331A3 (en) Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050620

MM4A Lapse of definitive patent protection due to non-payment of fees